MYGN
Myriad Genetics, Inc.Healthcare$4.74
▲ Bullish
Mkt Cap: $443.2MFloat: 85.1MSI: 13.7%DTC: 6.7
Data as of market close Apr 7, 2026
IV Rank
98
IV Pctl
83%
HV 20d
63.3%
52W Range
$4-$9
ATR(14)
$0.30
Exp. Move
±10.0%
P/C Ratio
0.28
Earnings
May 5
GEX Positive
DEX Long
Net Call Premium
IV High
Max Pain Below
Exp. Move Wide
Low Put/Call
MYGN Key Options Data
- IV Rank
- 97.9%
- Total GEX
- $0.00B
- Total DEX
- $0.0M
- Max Pain
- $4.00
- Expected Move
- ±10.0%
- Put/Call OI
- 0.28
- Net Premium
- $0.0M
- Spot Price
- $4.74
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-17 | 10 | ±$0.47 | ±10.0% | $4.26 | $5.21 |
| 2026-05-15 | 38 | ±$0.40 | ±8.4% | $4.34 | $5.14 |
| 2026-08-21 | 136 | ±$1.02 | ±21.6% | $3.71 | $5.76 |
Explore MYGN options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.